Skip to main content
Dec 02, 2020

Reduce surgical site infection with Temperature Controlled Airflow – a clinical validation of Improved outcomes

On the 54th Annual Conference of the German Society for Biomedical Engineering (BMT 2020), this year a virtual event, Prof Dr Clemens Bulitta et al presented two papers. 

The background to the first was a clinical validation of the efficacy of temperature-controlled ventilation system (TcAF) in the OR to reduce surgical site infections.

 The study was performed during live surgeries in one operating theater before and after a TcAF system Opragon had been installed. No changes were made to any other parameters relevant to infections and patients were of similar status. Endpoints for clinical outcome were length of stay and infection rates (SSI). A retrospective analysis of 1.000 total joint arthroplasties before and another 1.000 after installation of Opragon was performed. 

 A decrease of infectious complications (SSI) from 3.3% to 1.1% was shown, together with shorter hospital stay. 

 You can read more details from the study on our webpage

 Want to read the full abstract? Download it here


The Avidicare team is open to presentation and in-depth discussion on how the Opragon system can make a difference for both patients and hospital staff. 

Please contact us to receive a follow-up by an Opragon specialist.